Tumour-associated fibroblasts and mesenchymal stem cells: More similarities than differences

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 3, 2011, Pages 635-646

  Paunescu, Virgil ^a   Bojin, Florina M ^a   Tatu, Calin A ^b   Gavriliuc, Oana I ^a   Rosca, Adriana ^b   Gruia, Alexandra T ^b   Tanasie, Gabriela ^a   Bunu, Carmen ^a   Crisnic, Daniela ^a   Gherghiceanu, Mihaela ^c   Tatu, Fabian R ^a   Tatu, Carmen S ^a   Vermesan, Simona ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b County Hospital No1 Timisoara ^*  (Romania)

^c VICTOR BABES NATIONAL INSTITUTE OF PATHOLOGY   (Romania)

Author keywords

Cytokines; Growth factors; Mesenchymal stem cells (MSCs); Pluripotency; Tumour stroma; Tumour associated fibroblasts (TAFs)

Indexed keywords

ACTIN; BETA1 INTEGRIN; HERMES ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 1; INTERLEUKIN 10; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VIMENTIN;

ADIPOCYTE; ARTICLE; BONE MARROW CELL; BREAST TUMOR; CARTILAGE CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; FEMALE; FIBROBLAST; HUMAN; MESENCHYMAL STEM CELL; METABOLISM; OSTEOBLAST; PATHOLOGY; SMOOTH MUSCLE; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ACTINS; ADIPOCYTES; ANTIGENS, CD29; ANTIGENS, CD44; BONE MARROW CELLS; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CHONDROCYTES; FEMALE; FIBROBLASTS; HLA-DR ANTIGENS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; MESENCHYMAL STEM CELLS; MICROSCOPY, ELECTRON, TRANSMISSION; MUSCLE, SMOOTH; OSTEOBLASTS; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VIMENTIN;

EID: 79953309908     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01044.x     Document Type: Article

References (23)

1. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3: 393-403.
2. Stagg J. Mesenchymal stem cells in cancer. Stem Cell Rev. 2008; 4: 119-24.
3. Liotta LA, Kohn EC. The microenvironment of the tumor-host interface. Nature. 2001; 411: 375-9.
4. Pupa SM, Menard S, Forti S, et al New insights into the role of extracellular matrix during tumor onset and progression. J Cell Physiol. 2002; 192: 259-67.
5. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science. 2002; 296: 1046-49.
6. Spaeth EL, Dembinski JL, Sasser AK, et al Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One. 2009; 4: e4992.
7. Singh S, Ross SR, Acena M, et al Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells. J Exp Med. 1992; 175: 139-46.
8. Sullivan NJ, Hall BM. Mesenchymal stem cells in tumor stroma. In: Bagley RG, Teicher BA, editors. Stem cells and cancer. Berlin Springer; 2009. pp. 29-38.
9. Haniffa MA, Wang XN, Holtick U, et al Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol. 2007; 179: 1595-604.
10. Studeny M, Marini FC, Champlin RE, et al Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res. 2002; 62: 3603-8.
11. Studeny M, Marini FC, Dembinski JL, et al Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst. 2004; 96: 1593-603.
12. Sotiropoulou PA, Perez SA, Gritzapis AD, et al Interactions between human mesenchymal stem cells and natural killer cells. Stem Cells. 2006; 24: 74-85.
13. Spaggiari GM, Capobianco A, Becchetti S, et al Mesenchymal stem cell-natural killer cell interaction: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood. 2006; 107: 1484-90.
14. Poggi A, Prevosto C, Massaro AM, et al Interaction between NK cells and bone marrow stromal cells induces NK cell triggering: role of NKp30 and NKG2D receptors. J Immunol. 2005; 175: 6352-60.
15. Goldman RD, Khuon S, Chou Y, et al The function of intermediate filaments in cell shape and cytoskeletal integrity. J Cell Biol. 1996; 134: 971-83.
16. Katsumoto T, Mitsushima A, Kurimura T. The role of the vimentin intermediate filaments in rat 3Y1 cells elucidated by immunoelectron microscopy and computer-graphic reconstruction. Biol Cell. 1990; 68: 139-46.
17. Lysy PA, Smets F, Sibille C, et al Human skin fibroblasts: from mesodermal to hepatocyte-like differentiation. Hepatology. 2007; 46: 1574-85.
18. Hee CK, Nicoll SB. Induction of osteoblasts differentiation markers in human dermal fibroblasts: potential application to bone tissue engineering. Conf Proc IEEE Eng Med Biol Soc. 2006; 1: 521-4.
19. Sabatini F, Petecchia L, Tavian M, et al Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities. Lab Invest. 2005; 85: 962-71.
20. Pardali K, Moustakas A. Actions of TGF-beta as tumor suppressor and pro-metastatic factor in human cancer. Biochim Biophys Acta. 2007; 1775: 21-62.
21. Tse WT, Pendleton JD, Beyer WM, et al Suppression of allogenic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003; 75: 389-97.
22. Potian JA, Aviv H, Ponzio NM, et al Veto-like activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol. 2003; 171: 3426-34.
23. Le Blanc K, Tammik C, Rosendahl K, et al HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol. 2003; 31: 890-96.